Review



monoclonal antibody  (Cedarlane)


Bioz Verified Symbol Cedarlane is a verified supplier
Bioz Manufacturer Symbol Cedarlane manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cedarlane monoclonal antibody
    Monoclonal Antibody, supplied by Cedarlane, used in various techniques. Bioz Stars score: 96/100, based on 398 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl8942ap/Anti-Mouse%2FHuman+Mac-2+(Galectin-3)%2C+Purified+(Clone+M3%2F38)+(rat+IgG2a)/pmc13049657-436-25-27
    Average 96 stars, based on 398 article reviews
    monoclonal antibody - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Immunohistochemistry:

    Article Title: Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency
    Article Snippet: .. Sections for visceral organs and spinal cords were also evaluated by immunohistochemistry (IHC) , using the following primary antibodies: anti-Mac-2 clone M3/38 (1:600) (Cedarlane CL8942AP), anti-Lamp1 clone D2D11 (1:400) (Cell Signaling 9091 S) and anti-Cathepsin D clone EPR3057Y (1:1000) (Abcam ab75852). ..

    Virus:

    Article Title: Identification of the velum interpositum as a meningeal-CNS route for myeloid cell trafficking into the brain.
    Article Snippet: Article Identification of the velum interpositum as a meningeal-CNS route for myeloid cell trafficking into the brain Graphical abstract Highlights • The velum interpositum (VI) is a site for myeloid cell entry into the murine brain • The VI is a leptomeningeal extra-parenchymal structure • The VI contains meningeal macrophages and peripheral myeloid cells • Distinct myeloid cells utilize the VI during development and demyelinating disease Authors Lindsay A. Hohsfield, Sung Jin Kim, Rocio A. Barahona, ..., Xiangmin Xu, Thomas E. Lane, Kim N. Green Correspondence lhohsfie@uci.edu (L.A.H.), kngreen@uci.edu (K.N.G.). In brief Hohsfield et al. reveal a novel gateway for immune cells to enter the brain: the velum interpositum.. This structure serves as a crucial entry point for myeloid cells under various brain states.

    Recombinant:

    Article Title: Identification of the velum interpositum as a meningeal-CNS route for myeloid cell trafficking into the brain.
    Article Snippet: Article Identification of the velum interpositum as a meningeal-CNS route for myeloid cell trafficking into the brain Graphical abstract Highlights • The velum interpositum (VI) is a site for myeloid cell entry into the murine brain • The VI is a leptomeningeal extra-parenchymal structure • The VI contains meningeal macrophages and peripheral myeloid cells • Distinct myeloid cells utilize the VI during development and demyelinating disease Authors Lindsay A. Hohsfield, Sung Jin Kim, Rocio A. Barahona, ..., Xiangmin Xu, Thomas E. Lane, Kim N. Green Correspondence lhohsfie@uci.edu (L.A.H.), kngreen@uci.edu (K.N.G.). In brief Hohsfield et al. reveal a novel gateway for immune cells to enter the brain: the velum interpositum.. This structure serves as a crucial entry point for myeloid cells under various brain states.

    Article Title: TET3 plays a critical role in white adipose development and diet-induced remodeling.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HSP-90 Cell Signaling Cat# 4874; RRID:AB_2121214 GAPDH Cell Signaling Cat# 2118; RRID:AB_561053 Mouse (G3A1) mAb IgG1 Cell Signaling Cat# 5415; RRID:AB_10829607 FLAG Sigma Cat# F3165; RRID:AB_259529 PDGFRa-PE Invitrogen Cat# 12-1401-81; AB_657615 CD45-APC BD Biosciences Cat# 561018; RRID:AB_10584326 CD31-APC BD Biosciences Cat# 561814; RRID:AB_10893351 TER119-APC BD Biosciences Cat# 561033; RRID:AB_10584336 5mc Abcam Cat# ab10805; RRID:AB_442823 5hmc Active Motif Cat# 39769; RRID:AB_10013602 PPARg Santa Cruz Cat# sc-7273; RRID:AB_628115 MAC-2 Cedarlane Labs Cat# CL8942AP; RRID:AB_10060357 TET3 Millipore Cat# abe383 Chemicals, peptides, and recombinant proteins Insulin Sigma I5500 Dexamethasone Sigma D2915 isobutylmethylxanthine Sigma I5879 Puromycin Sigma P8833 Oil Red O Sigma O0625-100G Methylene blue Ricca Chemical 4880–100 Collagenase type 2 Fisher scientific NC9693955 Recombinant CILP protein Abcam 182802 TRI Reagent Solution Invitrogen AM9738 Dynabeads Protein G Invitrogen 10004D Dynabeads anti-mouse IgG Fisher scientific 11-201-D Protein assay dye reagent Bio-Rad 5000006 BSA Sigma A7906 Lipofectamine 3000 Invitrogen L3000-015 Critical commercial assays High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 4368813 SYBR green qPCR master mix Bioneer K-6251 mouse leptin ELISA Kit Crystal Chem 90030 ultrasensitive mouse Insulin ELISA kit Crystal Chem 90080 DNeasy Blood & Tissue kit Qiagen 69504 APO-BrdU Fragmentation Assay Kit BioVision K401 RNAqueous -Micro Kit Invitrogen AM1931 ECL Assay Kit PerkinElmer NEL104001EA Dual-Luciferase Reporter Assay System Promega E1980 Hydroxyproline Colorimetric Assay kit BioVision K555 Serum Triglyceride Determination Kit Sigma TR0100 Deposited data Whole genome bisulfite sequencing (WGBS) and RNA-sequencing of preadipocytes from iWAT N/A GSE214483 (Continued on next page) Cell Reports 42, 113196, October 31, 2023 15 .. REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines 3T3-L1 ATCC CL-173 HEK293T ATCC CRL-3216 Experimental models: Organisms/strains Mouse: C57BL/6J Jackson Laboratory 000664 Mouse: Pdgfra-Tet3 KO Dr. Anjana Rao and Jackson Laboratory N/A Oligonucleotides qPCR primer sequences Integrated DNA technologies Table S2 gRNA Integrated DNA technologies Table S2 ChIP-qPCR Integrated DNA technologies Table S2 MeDIP Integrated DNA technologies Table S2 Recombinant DNA pM2DG gift from Dr. Didier Trono Addgene, #12259 psPAX2 gift from Dr. Didier Trono Addgene, #12260 pCDH-CMV-MCS-EF1 System Biosciences CD510B-1 pLKO.1 gift from Dr. David Root74 Addgene, #10878 pLN-U6-gRNA Dr. Andreas Stahl N/A pCpGL3-Basic Dr. Michael Rehli N/A Software and algorithms QuantStudio 5 Applied Biosystems A34322 iBrightTM CL1500 Imaging System Invitrogen A44114 ImageJ National Institutes of Health https://imagej.nih.gov/ij/ Adiposoft75 Galarraga et al.75 https://drive.google.com/file/d/ 1TjfoogPQK2NB4VRpZxVn-BgcziCqrS8S/view Hisat276 Kim et al.76 https://github.com/DaehwanKimLab/hisat2 Htseq77 Anders et al.77 https://github.com/simon-anders/htseq Deseq278 Love et al.78 https://github.com/thelovelab/DESeq2 GSEApy79 Fang et al.79 https://github.com/zqfang/GSEApy/tree/v0.9.18 Bismark80 Krueger et al.80 https://github.com/FelixKrueger/Bismark DSS81 Wu et al.81 https://github.com/haowulab/DSS/ GREAT82 McLean et al.82 http://great.stanford.edu/public/html/ Homer83 Heinz, S. et al.83 http://homer.ucsd.edu/homer/ FastQC Andrews, S.84 https://github.com/s-andrews/FastQC TrimGalore Altos Labs https://github.com/FelixKrueger/TrimGalore GraphPad Prism GraphPad https://www.graphpad.com/ Other High fat diet Research Diets D12331i

    Saline:

    Article Title: Identification of the velum interpositum as a meningeal-CNS route for myeloid cell trafficking into the brain.
    Article Snippet: Article Identification of the velum interpositum as a meningeal-CNS route for myeloid cell trafficking into the brain Graphical abstract Highlights • The velum interpositum (VI) is a site for myeloid cell entry into the murine brain • The VI is a leptomeningeal extra-parenchymal structure • The VI contains meningeal macrophages and peripheral myeloid cells • Distinct myeloid cells utilize the VI during development and demyelinating disease Authors Lindsay A. Hohsfield, Sung Jin Kim, Rocio A. Barahona, ..., Xiangmin Xu, Thomas E. Lane, Kim N. Green Correspondence lhohsfie@uci.edu (L.A.H.), kngreen@uci.edu (K.N.G.). In brief Hohsfield et al. reveal a novel gateway for immune cells to enter the brain: the velum interpositum.. This structure serves as a crucial entry point for myeloid cells under various brain states.

    Incubation:

    Article Title: Dietary depletion of glutamine is atheroprotective
    Article Snippet: The next day the slides were washed with 1× PBS + 0.1% Tween-20 and 1× PBS for five minutes each and incubated in donkey anti-rabbit IgG Alexa Fluor 546 at 1:250 dilution, (ThermoFisher; cat#: A10040). .. After an additional wash step, slides were incubated in rat anti-LGALS3 at 1:500 dilution (Cedarlane; cat#: CL8942AP) for one hour. .. Donkey anti-goat conjugated to Alexa 647 at 1:250 dilution (Invitrogen; cat#: A21447), mouse monoclonal SM α-actin-FITC at 1:250 dilution (ACTA2) (clone 1A4, Sigma Aldrich; cat#: F3337), and DAPI at 1:100 dilution (5 mg/mL; Invitrogen; cat#: D21490) were all added after a wash step and left to incubate for one hour at RT.

    Article Title: An mTORC1 ‐Dependent Mouse Model for Cardiac Sarcoidosis
    Article Snippet: .. Following citrate antigen retrieval, slides were incubated overnight at 4 °C with primary antibodies: anti‐Galectin 3 (Mac‐2) (Abcam, ab76245 or Cedarlane CL8942AP), rabbit monoclonal anti‐Phospho‐S6 Ribosomal Protein (p‐S6) (Ser240/244) (Cell Signaling Technology, 5364S), rabbit polyclonal anti‐N‐Cadherin (Merck, C3678), rabbit monoclonal anti‐gamma Catenin (plakoglobin) (Abcam, ab184919), rabbit polyclonal anti‐Connexin 43 (Merck, C6219), rabbit monoclonal anti‐CD3 (Abcam, ab5690), CD206 polyclonal antibody (Thermo Fisher PA5‐46994), or rat anti‐CD68 (Thermo Fisher, 14–0681‐82). .. The next day, heart sections were incubated with host‐specific Cy3‐conjugated secondary antibodies and mounted with ProLong Gold (Invitrogen, P36935).

    other:


    Article Title: Microglial colonization of the developing mouse brain is controlled by both microglial and neural CSF-1
    Article Snippet: Rat anti-GAL3 , Cedarlane , Cat# CL8942AP.

    Reverse Transcription:

    Article Title: TET3 plays a critical role in white adipose development and diet-induced remodeling.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HSP-90 Cell Signaling Cat# 4874; RRID:AB_2121214 GAPDH Cell Signaling Cat# 2118; RRID:AB_561053 Mouse (G3A1) mAb IgG1 Cell Signaling Cat# 5415; RRID:AB_10829607 FLAG Sigma Cat# F3165; RRID:AB_259529 PDGFRa-PE Invitrogen Cat# 12-1401-81; AB_657615 CD45-APC BD Biosciences Cat# 561018; RRID:AB_10584326 CD31-APC BD Biosciences Cat# 561814; RRID:AB_10893351 TER119-APC BD Biosciences Cat# 561033; RRID:AB_10584336 5mc Abcam Cat# ab10805; RRID:AB_442823 5hmc Active Motif Cat# 39769; RRID:AB_10013602 PPARg Santa Cruz Cat# sc-7273; RRID:AB_628115 MAC-2 Cedarlane Labs Cat# CL8942AP; RRID:AB_10060357 TET3 Millipore Cat# abe383 Chemicals, peptides, and recombinant proteins Insulin Sigma I5500 Dexamethasone Sigma D2915 isobutylmethylxanthine Sigma I5879 Puromycin Sigma P8833 Oil Red O Sigma O0625-100G Methylene blue Ricca Chemical 4880–100 Collagenase type 2 Fisher scientific NC9693955 Recombinant CILP protein Abcam 182802 TRI Reagent Solution Invitrogen AM9738 Dynabeads Protein G Invitrogen 10004D Dynabeads anti-mouse IgG Fisher scientific 11-201-D Protein assay dye reagent Bio-Rad 5000006 BSA Sigma A7906 Lipofectamine 3000 Invitrogen L3000-015 Critical commercial assays High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 4368813 SYBR green qPCR master mix Bioneer K-6251 mouse leptin ELISA Kit Crystal Chem 90030 ultrasensitive mouse Insulin ELISA kit Crystal Chem 90080 DNeasy Blood & Tissue kit Qiagen 69504 APO-BrdU Fragmentation Assay Kit BioVision K401 RNAqueous -Micro Kit Invitrogen AM1931 ECL Assay Kit PerkinElmer NEL104001EA Dual-Luciferase Reporter Assay System Promega E1980 Hydroxyproline Colorimetric Assay kit BioVision K555 Serum Triglyceride Determination Kit Sigma TR0100 Deposited data Whole genome bisulfite sequencing (WGBS) and RNA-sequencing of preadipocytes from iWAT N/A GSE214483 (Continued on next page) Cell Reports 42, 113196, October 31, 2023 15 .. REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines 3T3-L1 ATCC CL-173 HEK293T ATCC CRL-3216 Experimental models: Organisms/strains Mouse: C57BL/6J Jackson Laboratory 000664 Mouse: Pdgfra-Tet3 KO Dr. Anjana Rao and Jackson Laboratory N/A Oligonucleotides qPCR primer sequences Integrated DNA technologies Table S2 gRNA Integrated DNA technologies Table S2 ChIP-qPCR Integrated DNA technologies Table S2 MeDIP Integrated DNA technologies Table S2 Recombinant DNA pM2DG gift from Dr. Didier Trono Addgene, #12259 psPAX2 gift from Dr. Didier Trono Addgene, #12260 pCDH-CMV-MCS-EF1 System Biosciences CD510B-1 pLKO.1 gift from Dr. David Root74 Addgene, #10878 pLN-U6-gRNA Dr. Andreas Stahl N/A pCpGL3-Basic Dr. Michael Rehli N/A Software and algorithms QuantStudio 5 Applied Biosystems A34322 iBrightTM CL1500 Imaging System Invitrogen A44114 ImageJ National Institutes of Health https://imagej.nih.gov/ij/ Adiposoft75 Galarraga et al.75 https://drive.google.com/file/d/ 1TjfoogPQK2NB4VRpZxVn-BgcziCqrS8S/view Hisat276 Kim et al.76 https://github.com/DaehwanKimLab/hisat2 Htseq77 Anders et al.77 https://github.com/simon-anders/htseq Deseq278 Love et al.78 https://github.com/thelovelab/DESeq2 GSEApy79 Fang et al.79 https://github.com/zqfang/GSEApy/tree/v0.9.18 Bismark80 Krueger et al.80 https://github.com/FelixKrueger/Bismark DSS81 Wu et al.81 https://github.com/haowulab/DSS/ GREAT82 McLean et al.82 http://great.stanford.edu/public/html/ Homer83 Heinz, S. et al.83 http://homer.ucsd.edu/homer/ FastQC Andrews, S.84 https://github.com/s-andrews/FastQC TrimGalore Altos Labs https://github.com/FelixKrueger/TrimGalore GraphPad Prism GraphPad https://www.graphpad.com/ Other High fat diet Research Diets D12331i

    SYBR Green Assay:

    Article Title: TET3 plays a critical role in white adipose development and diet-induced remodeling.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HSP-90 Cell Signaling Cat# 4874; RRID:AB_2121214 GAPDH Cell Signaling Cat# 2118; RRID:AB_561053 Mouse (G3A1) mAb IgG1 Cell Signaling Cat# 5415; RRID:AB_10829607 FLAG Sigma Cat# F3165; RRID:AB_259529 PDGFRa-PE Invitrogen Cat# 12-1401-81; AB_657615 CD45-APC BD Biosciences Cat# 561018; RRID:AB_10584326 CD31-APC BD Biosciences Cat# 561814; RRID:AB_10893351 TER119-APC BD Biosciences Cat# 561033; RRID:AB_10584336 5mc Abcam Cat# ab10805; RRID:AB_442823 5hmc Active Motif Cat# 39769; RRID:AB_10013602 PPARg Santa Cruz Cat# sc-7273; RRID:AB_628115 MAC-2 Cedarlane Labs Cat# CL8942AP; RRID:AB_10060357 TET3 Millipore Cat# abe383 Chemicals, peptides, and recombinant proteins Insulin Sigma I5500 Dexamethasone Sigma D2915 isobutylmethylxanthine Sigma I5879 Puromycin Sigma P8833 Oil Red O Sigma O0625-100G Methylene blue Ricca Chemical 4880–100 Collagenase type 2 Fisher scientific NC9693955 Recombinant CILP protein Abcam 182802 TRI Reagent Solution Invitrogen AM9738 Dynabeads Protein G Invitrogen 10004D Dynabeads anti-mouse IgG Fisher scientific 11-201-D Protein assay dye reagent Bio-Rad 5000006 BSA Sigma A7906 Lipofectamine 3000 Invitrogen L3000-015 Critical commercial assays High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 4368813 SYBR green qPCR master mix Bioneer K-6251 mouse leptin ELISA Kit Crystal Chem 90030 ultrasensitive mouse Insulin ELISA kit Crystal Chem 90080 DNeasy Blood & Tissue kit Qiagen 69504 APO-BrdU Fragmentation Assay Kit BioVision K401 RNAqueous -Micro Kit Invitrogen AM1931 ECL Assay Kit PerkinElmer NEL104001EA Dual-Luciferase Reporter Assay System Promega E1980 Hydroxyproline Colorimetric Assay kit BioVision K555 Serum Triglyceride Determination Kit Sigma TR0100 Deposited data Whole genome bisulfite sequencing (WGBS) and RNA-sequencing of preadipocytes from iWAT N/A GSE214483 (Continued on next page) Cell Reports 42, 113196, October 31, 2023 15 .. REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines 3T3-L1 ATCC CL-173 HEK293T ATCC CRL-3216 Experimental models: Organisms/strains Mouse: C57BL/6J Jackson Laboratory 000664 Mouse: Pdgfra-Tet3 KO Dr. Anjana Rao and Jackson Laboratory N/A Oligonucleotides qPCR primer sequences Integrated DNA technologies Table S2 gRNA Integrated DNA technologies Table S2 ChIP-qPCR Integrated DNA technologies Table S2 MeDIP Integrated DNA technologies Table S2 Recombinant DNA pM2DG gift from Dr. Didier Trono Addgene, #12259 psPAX2 gift from Dr. Didier Trono Addgene, #12260 pCDH-CMV-MCS-EF1 System Biosciences CD510B-1 pLKO.1 gift from Dr. David Root74 Addgene, #10878 pLN-U6-gRNA Dr. Andreas Stahl N/A pCpGL3-Basic Dr. Michael Rehli N/A Software and algorithms QuantStudio 5 Applied Biosystems A34322 iBrightTM CL1500 Imaging System Invitrogen A44114 ImageJ National Institutes of Health https://imagej.nih.gov/ij/ Adiposoft75 Galarraga et al.75 https://drive.google.com/file/d/ 1TjfoogPQK2NB4VRpZxVn-BgcziCqrS8S/view Hisat276 Kim et al.76 https://github.com/DaehwanKimLab/hisat2 Htseq77 Anders et al.77 https://github.com/simon-anders/htseq Deseq278 Love et al.78 https://github.com/thelovelab/DESeq2 GSEApy79 Fang et al.79 https://github.com/zqfang/GSEApy/tree/v0.9.18 Bismark80 Krueger et al.80 https://github.com/FelixKrueger/Bismark DSS81 Wu et al.81 https://github.com/haowulab/DSS/ GREAT82 McLean et al.82 http://great.stanford.edu/public/html/ Homer83 Heinz, S. et al.83 http://homer.ucsd.edu/homer/ FastQC Andrews, S.84 https://github.com/s-andrews/FastQC TrimGalore Altos Labs https://github.com/FelixKrueger/TrimGalore GraphPad Prism GraphPad https://www.graphpad.com/ Other High fat diet Research Diets D12331i

    Real-time Polymerase Chain Reaction:

    Article Title: TET3 plays a critical role in white adipose development and diet-induced remodeling.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HSP-90 Cell Signaling Cat# 4874; RRID:AB_2121214 GAPDH Cell Signaling Cat# 2118; RRID:AB_561053 Mouse (G3A1) mAb IgG1 Cell Signaling Cat# 5415; RRID:AB_10829607 FLAG Sigma Cat# F3165; RRID:AB_259529 PDGFRa-PE Invitrogen Cat# 12-1401-81; AB_657615 CD45-APC BD Biosciences Cat# 561018; RRID:AB_10584326 CD31-APC BD Biosciences Cat# 561814; RRID:AB_10893351 TER119-APC BD Biosciences Cat# 561033; RRID:AB_10584336 5mc Abcam Cat# ab10805; RRID:AB_442823 5hmc Active Motif Cat# 39769; RRID:AB_10013602 PPARg Santa Cruz Cat# sc-7273; RRID:AB_628115 MAC-2 Cedarlane Labs Cat# CL8942AP; RRID:AB_10060357 TET3 Millipore Cat# abe383 Chemicals, peptides, and recombinant proteins Insulin Sigma I5500 Dexamethasone Sigma D2915 isobutylmethylxanthine Sigma I5879 Puromycin Sigma P8833 Oil Red O Sigma O0625-100G Methylene blue Ricca Chemical 4880–100 Collagenase type 2 Fisher scientific NC9693955 Recombinant CILP protein Abcam 182802 TRI Reagent Solution Invitrogen AM9738 Dynabeads Protein G Invitrogen 10004D Dynabeads anti-mouse IgG Fisher scientific 11-201-D Protein assay dye reagent Bio-Rad 5000006 BSA Sigma A7906 Lipofectamine 3000 Invitrogen L3000-015 Critical commercial assays High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 4368813 SYBR green qPCR master mix Bioneer K-6251 mouse leptin ELISA Kit Crystal Chem 90030 ultrasensitive mouse Insulin ELISA kit Crystal Chem 90080 DNeasy Blood & Tissue kit Qiagen 69504 APO-BrdU Fragmentation Assay Kit BioVision K401 RNAqueous -Micro Kit Invitrogen AM1931 ECL Assay Kit PerkinElmer NEL104001EA Dual-Luciferase Reporter Assay System Promega E1980 Hydroxyproline Colorimetric Assay kit BioVision K555 Serum Triglyceride Determination Kit Sigma TR0100 Deposited data Whole genome bisulfite sequencing (WGBS) and RNA-sequencing of preadipocytes from iWAT N/A GSE214483 (Continued on next page) Cell Reports 42, 113196, October 31, 2023 15 .. REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines 3T3-L1 ATCC CL-173 HEK293T ATCC CRL-3216 Experimental models: Organisms/strains Mouse: C57BL/6J Jackson Laboratory 000664 Mouse: Pdgfra-Tet3 KO Dr. Anjana Rao and Jackson Laboratory N/A Oligonucleotides qPCR primer sequences Integrated DNA technologies Table S2 gRNA Integrated DNA technologies Table S2 ChIP-qPCR Integrated DNA technologies Table S2 MeDIP Integrated DNA technologies Table S2 Recombinant DNA pM2DG gift from Dr. Didier Trono Addgene, #12259 psPAX2 gift from Dr. Didier Trono Addgene, #12260 pCDH-CMV-MCS-EF1 System Biosciences CD510B-1 pLKO.1 gift from Dr. David Root74 Addgene, #10878 pLN-U6-gRNA Dr. Andreas Stahl N/A pCpGL3-Basic Dr. Michael Rehli N/A Software and algorithms QuantStudio 5 Applied Biosystems A34322 iBrightTM CL1500 Imaging System Invitrogen A44114 ImageJ National Institutes of Health https://imagej.nih.gov/ij/ Adiposoft75 Galarraga et al.75 https://drive.google.com/file/d/ 1TjfoogPQK2NB4VRpZxVn-BgcziCqrS8S/view Hisat276 Kim et al.76 https://github.com/DaehwanKimLab/hisat2 Htseq77 Anders et al.77 https://github.com/simon-anders/htseq Deseq278 Love et al.78 https://github.com/thelovelab/DESeq2 GSEApy79 Fang et al.79 https://github.com/zqfang/GSEApy/tree/v0.9.18 Bismark80 Krueger et al.80 https://github.com/FelixKrueger/Bismark DSS81 Wu et al.81 https://github.com/haowulab/DSS/ GREAT82 McLean et al.82 http://great.stanford.edu/public/html/ Homer83 Heinz, S. et al.83 http://homer.ucsd.edu/homer/ FastQC Andrews, S.84 https://github.com/s-andrews/FastQC TrimGalore Altos Labs https://github.com/FelixKrueger/TrimGalore GraphPad Prism GraphPad https://www.graphpad.com/ Other High fat diet Research Diets D12331i

    Enzyme-linked Immunosorbent Assay:

    Article Title: TET3 plays a critical role in white adipose development and diet-induced remodeling.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HSP-90 Cell Signaling Cat# 4874; RRID:AB_2121214 GAPDH Cell Signaling Cat# 2118; RRID:AB_561053 Mouse (G3A1) mAb IgG1 Cell Signaling Cat# 5415; RRID:AB_10829607 FLAG Sigma Cat# F3165; RRID:AB_259529 PDGFRa-PE Invitrogen Cat# 12-1401-81; AB_657615 CD45-APC BD Biosciences Cat# 561018; RRID:AB_10584326 CD31-APC BD Biosciences Cat# 561814; RRID:AB_10893351 TER119-APC BD Biosciences Cat# 561033; RRID:AB_10584336 5mc Abcam Cat# ab10805; RRID:AB_442823 5hmc Active Motif Cat# 39769; RRID:AB_10013602 PPARg Santa Cruz Cat# sc-7273; RRID:AB_628115 MAC-2 Cedarlane Labs Cat# CL8942AP; RRID:AB_10060357 TET3 Millipore Cat# abe383 Chemicals, peptides, and recombinant proteins Insulin Sigma I5500 Dexamethasone Sigma D2915 isobutylmethylxanthine Sigma I5879 Puromycin Sigma P8833 Oil Red O Sigma O0625-100G Methylene blue Ricca Chemical 4880–100 Collagenase type 2 Fisher scientific NC9693955 Recombinant CILP protein Abcam 182802 TRI Reagent Solution Invitrogen AM9738 Dynabeads Protein G Invitrogen 10004D Dynabeads anti-mouse IgG Fisher scientific 11-201-D Protein assay dye reagent Bio-Rad 5000006 BSA Sigma A7906 Lipofectamine 3000 Invitrogen L3000-015 Critical commercial assays High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 4368813 SYBR green qPCR master mix Bioneer K-6251 mouse leptin ELISA Kit Crystal Chem 90030 ultrasensitive mouse Insulin ELISA kit Crystal Chem 90080 DNeasy Blood & Tissue kit Qiagen 69504 APO-BrdU Fragmentation Assay Kit BioVision K401 RNAqueous -Micro Kit Invitrogen AM1931 ECL Assay Kit PerkinElmer NEL104001EA Dual-Luciferase Reporter Assay System Promega E1980 Hydroxyproline Colorimetric Assay kit BioVision K555 Serum Triglyceride Determination Kit Sigma TR0100 Deposited data Whole genome bisulfite sequencing (WGBS) and RNA-sequencing of preadipocytes from iWAT N/A GSE214483 (Continued on next page) Cell Reports 42, 113196, October 31, 2023 15 .. REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines 3T3-L1 ATCC CL-173 HEK293T ATCC CRL-3216 Experimental models: Organisms/strains Mouse: C57BL/6J Jackson Laboratory 000664 Mouse: Pdgfra-Tet3 KO Dr. Anjana Rao and Jackson Laboratory N/A Oligonucleotides qPCR primer sequences Integrated DNA technologies Table S2 gRNA Integrated DNA technologies Table S2 ChIP-qPCR Integrated DNA technologies Table S2 MeDIP Integrated DNA technologies Table S2 Recombinant DNA pM2DG gift from Dr. Didier Trono Addgene, #12259 psPAX2 gift from Dr. Didier Trono Addgene, #12260 pCDH-CMV-MCS-EF1 System Biosciences CD510B-1 pLKO.1 gift from Dr. David Root74 Addgene, #10878 pLN-U6-gRNA Dr. Andreas Stahl N/A pCpGL3-Basic Dr. Michael Rehli N/A Software and algorithms QuantStudio 5 Applied Biosystems A34322 iBrightTM CL1500 Imaging System Invitrogen A44114 ImageJ National Institutes of Health https://imagej.nih.gov/ij/ Adiposoft75 Galarraga et al.75 https://drive.google.com/file/d/ 1TjfoogPQK2NB4VRpZxVn-BgcziCqrS8S/view Hisat276 Kim et al.76 https://github.com/DaehwanKimLab/hisat2 Htseq77 Anders et al.77 https://github.com/simon-anders/htseq Deseq278 Love et al.78 https://github.com/thelovelab/DESeq2 GSEApy79 Fang et al.79 https://github.com/zqfang/GSEApy/tree/v0.9.18 Bismark80 Krueger et al.80 https://github.com/FelixKrueger/Bismark DSS81 Wu et al.81 https://github.com/haowulab/DSS/ GREAT82 McLean et al.82 http://great.stanford.edu/public/html/ Homer83 Heinz, S. et al.83 http://homer.ucsd.edu/homer/ FastQC Andrews, S.84 https://github.com/s-andrews/FastQC TrimGalore Altos Labs https://github.com/FelixKrueger/TrimGalore GraphPad Prism GraphPad https://www.graphpad.com/ Other High fat diet Research Diets D12331i

    Reporter Assay:

    Article Title: TET3 plays a critical role in white adipose development and diet-induced remodeling.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HSP-90 Cell Signaling Cat# 4874; RRID:AB_2121214 GAPDH Cell Signaling Cat# 2118; RRID:AB_561053 Mouse (G3A1) mAb IgG1 Cell Signaling Cat# 5415; RRID:AB_10829607 FLAG Sigma Cat# F3165; RRID:AB_259529 PDGFRa-PE Invitrogen Cat# 12-1401-81; AB_657615 CD45-APC BD Biosciences Cat# 561018; RRID:AB_10584326 CD31-APC BD Biosciences Cat# 561814; RRID:AB_10893351 TER119-APC BD Biosciences Cat# 561033; RRID:AB_10584336 5mc Abcam Cat# ab10805; RRID:AB_442823 5hmc Active Motif Cat# 39769; RRID:AB_10013602 PPARg Santa Cruz Cat# sc-7273; RRID:AB_628115 MAC-2 Cedarlane Labs Cat# CL8942AP; RRID:AB_10060357 TET3 Millipore Cat# abe383 Chemicals, peptides, and recombinant proteins Insulin Sigma I5500 Dexamethasone Sigma D2915 isobutylmethylxanthine Sigma I5879 Puromycin Sigma P8833 Oil Red O Sigma O0625-100G Methylene blue Ricca Chemical 4880–100 Collagenase type 2 Fisher scientific NC9693955 Recombinant CILP protein Abcam 182802 TRI Reagent Solution Invitrogen AM9738 Dynabeads Protein G Invitrogen 10004D Dynabeads anti-mouse IgG Fisher scientific 11-201-D Protein assay dye reagent Bio-Rad 5000006 BSA Sigma A7906 Lipofectamine 3000 Invitrogen L3000-015 Critical commercial assays High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 4368813 SYBR green qPCR master mix Bioneer K-6251 mouse leptin ELISA Kit Crystal Chem 90030 ultrasensitive mouse Insulin ELISA kit Crystal Chem 90080 DNeasy Blood & Tissue kit Qiagen 69504 APO-BrdU Fragmentation Assay Kit BioVision K401 RNAqueous -Micro Kit Invitrogen AM1931 ECL Assay Kit PerkinElmer NEL104001EA Dual-Luciferase Reporter Assay System Promega E1980 Hydroxyproline Colorimetric Assay kit BioVision K555 Serum Triglyceride Determination Kit Sigma TR0100 Deposited data Whole genome bisulfite sequencing (WGBS) and RNA-sequencing of preadipocytes from iWAT N/A GSE214483 (Continued on next page) Cell Reports 42, 113196, October 31, 2023 15 .. REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines 3T3-L1 ATCC CL-173 HEK293T ATCC CRL-3216 Experimental models: Organisms/strains Mouse: C57BL/6J Jackson Laboratory 000664 Mouse: Pdgfra-Tet3 KO Dr. Anjana Rao and Jackson Laboratory N/A Oligonucleotides qPCR primer sequences Integrated DNA technologies Table S2 gRNA Integrated DNA technologies Table S2 ChIP-qPCR Integrated DNA technologies Table S2 MeDIP Integrated DNA technologies Table S2 Recombinant DNA pM2DG gift from Dr. Didier Trono Addgene, #12259 psPAX2 gift from Dr. Didier Trono Addgene, #12260 pCDH-CMV-MCS-EF1 System Biosciences CD510B-1 pLKO.1 gift from Dr. David Root74 Addgene, #10878 pLN-U6-gRNA Dr. Andreas Stahl N/A pCpGL3-Basic Dr. Michael Rehli N/A Software and algorithms QuantStudio 5 Applied Biosystems A34322 iBrightTM CL1500 Imaging System Invitrogen A44114 ImageJ National Institutes of Health https://imagej.nih.gov/ij/ Adiposoft75 Galarraga et al.75 https://drive.google.com/file/d/ 1TjfoogPQK2NB4VRpZxVn-BgcziCqrS8S/view Hisat276 Kim et al.76 https://github.com/DaehwanKimLab/hisat2 Htseq77 Anders et al.77 https://github.com/simon-anders/htseq Deseq278 Love et al.78 https://github.com/thelovelab/DESeq2 GSEApy79 Fang et al.79 https://github.com/zqfang/GSEApy/tree/v0.9.18 Bismark80 Krueger et al.80 https://github.com/FelixKrueger/Bismark DSS81 Wu et al.81 https://github.com/haowulab/DSS/ GREAT82 McLean et al.82 http://great.stanford.edu/public/html/ Homer83 Heinz, S. et al.83 http://homer.ucsd.edu/homer/ FastQC Andrews, S.84 https://github.com/s-andrews/FastQC TrimGalore Altos Labs https://github.com/FelixKrueger/TrimGalore GraphPad Prism GraphPad https://www.graphpad.com/ Other High fat diet Research Diets D12331i

    Colorimetric Assay:

    Article Title: TET3 plays a critical role in white adipose development and diet-induced remodeling.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HSP-90 Cell Signaling Cat# 4874; RRID:AB_2121214 GAPDH Cell Signaling Cat# 2118; RRID:AB_561053 Mouse (G3A1) mAb IgG1 Cell Signaling Cat# 5415; RRID:AB_10829607 FLAG Sigma Cat# F3165; RRID:AB_259529 PDGFRa-PE Invitrogen Cat# 12-1401-81; AB_657615 CD45-APC BD Biosciences Cat# 561018; RRID:AB_10584326 CD31-APC BD Biosciences Cat# 561814; RRID:AB_10893351 TER119-APC BD Biosciences Cat# 561033; RRID:AB_10584336 5mc Abcam Cat# ab10805; RRID:AB_442823 5hmc Active Motif Cat# 39769; RRID:AB_10013602 PPARg Santa Cruz Cat# sc-7273; RRID:AB_628115 MAC-2 Cedarlane Labs Cat# CL8942AP; RRID:AB_10060357 TET3 Millipore Cat# abe383 Chemicals, peptides, and recombinant proteins Insulin Sigma I5500 Dexamethasone Sigma D2915 isobutylmethylxanthine Sigma I5879 Puromycin Sigma P8833 Oil Red O Sigma O0625-100G Methylene blue Ricca Chemical 4880–100 Collagenase type 2 Fisher scientific NC9693955 Recombinant CILP protein Abcam 182802 TRI Reagent Solution Invitrogen AM9738 Dynabeads Protein G Invitrogen 10004D Dynabeads anti-mouse IgG Fisher scientific 11-201-D Protein assay dye reagent Bio-Rad 5000006 BSA Sigma A7906 Lipofectamine 3000 Invitrogen L3000-015 Critical commercial assays High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 4368813 SYBR green qPCR master mix Bioneer K-6251 mouse leptin ELISA Kit Crystal Chem 90030 ultrasensitive mouse Insulin ELISA kit Crystal Chem 90080 DNeasy Blood & Tissue kit Qiagen 69504 APO-BrdU Fragmentation Assay Kit BioVision K401 RNAqueous -Micro Kit Invitrogen AM1931 ECL Assay Kit PerkinElmer NEL104001EA Dual-Luciferase Reporter Assay System Promega E1980 Hydroxyproline Colorimetric Assay kit BioVision K555 Serum Triglyceride Determination Kit Sigma TR0100 Deposited data Whole genome bisulfite sequencing (WGBS) and RNA-sequencing of preadipocytes from iWAT N/A GSE214483 (Continued on next page) Cell Reports 42, 113196, October 31, 2023 15 .. REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines 3T3-L1 ATCC CL-173 HEK293T ATCC CRL-3216 Experimental models: Organisms/strains Mouse: C57BL/6J Jackson Laboratory 000664 Mouse: Pdgfra-Tet3 KO Dr. Anjana Rao and Jackson Laboratory N/A Oligonucleotides qPCR primer sequences Integrated DNA technologies Table S2 gRNA Integrated DNA technologies Table S2 ChIP-qPCR Integrated DNA technologies Table S2 MeDIP Integrated DNA technologies Table S2 Recombinant DNA pM2DG gift from Dr. Didier Trono Addgene, #12259 psPAX2 gift from Dr. Didier Trono Addgene, #12260 pCDH-CMV-MCS-EF1 System Biosciences CD510B-1 pLKO.1 gift from Dr. David Root74 Addgene, #10878 pLN-U6-gRNA Dr. Andreas Stahl N/A pCpGL3-Basic Dr. Michael Rehli N/A Software and algorithms QuantStudio 5 Applied Biosystems A34322 iBrightTM CL1500 Imaging System Invitrogen A44114 ImageJ National Institutes of Health https://imagej.nih.gov/ij/ Adiposoft75 Galarraga et al.75 https://drive.google.com/file/d/ 1TjfoogPQK2NB4VRpZxVn-BgcziCqrS8S/view Hisat276 Kim et al.76 https://github.com/DaehwanKimLab/hisat2 Htseq77 Anders et al.77 https://github.com/simon-anders/htseq Deseq278 Love et al.78 https://github.com/thelovelab/DESeq2 GSEApy79 Fang et al.79 https://github.com/zqfang/GSEApy/tree/v0.9.18 Bismark80 Krueger et al.80 https://github.com/FelixKrueger/Bismark DSS81 Wu et al.81 https://github.com/haowulab/DSS/ GREAT82 McLean et al.82 http://great.stanford.edu/public/html/ Homer83 Heinz, S. et al.83 http://homer.ucsd.edu/homer/ FastQC Andrews, S.84 https://github.com/s-andrews/FastQC TrimGalore Altos Labs https://github.com/FelixKrueger/TrimGalore GraphPad Prism GraphPad https://www.graphpad.com/ Other High fat diet Research Diets D12331i

    Methylation Sequencing:

    Article Title: TET3 plays a critical role in white adipose development and diet-induced remodeling.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HSP-90 Cell Signaling Cat# 4874; RRID:AB_2121214 GAPDH Cell Signaling Cat# 2118; RRID:AB_561053 Mouse (G3A1) mAb IgG1 Cell Signaling Cat# 5415; RRID:AB_10829607 FLAG Sigma Cat# F3165; RRID:AB_259529 PDGFRa-PE Invitrogen Cat# 12-1401-81; AB_657615 CD45-APC BD Biosciences Cat# 561018; RRID:AB_10584326 CD31-APC BD Biosciences Cat# 561814; RRID:AB_10893351 TER119-APC BD Biosciences Cat# 561033; RRID:AB_10584336 5mc Abcam Cat# ab10805; RRID:AB_442823 5hmc Active Motif Cat# 39769; RRID:AB_10013602 PPARg Santa Cruz Cat# sc-7273; RRID:AB_628115 MAC-2 Cedarlane Labs Cat# CL8942AP; RRID:AB_10060357 TET3 Millipore Cat# abe383 Chemicals, peptides, and recombinant proteins Insulin Sigma I5500 Dexamethasone Sigma D2915 isobutylmethylxanthine Sigma I5879 Puromycin Sigma P8833 Oil Red O Sigma O0625-100G Methylene blue Ricca Chemical 4880–100 Collagenase type 2 Fisher scientific NC9693955 Recombinant CILP protein Abcam 182802 TRI Reagent Solution Invitrogen AM9738 Dynabeads Protein G Invitrogen 10004D Dynabeads anti-mouse IgG Fisher scientific 11-201-D Protein assay dye reagent Bio-Rad 5000006 BSA Sigma A7906 Lipofectamine 3000 Invitrogen L3000-015 Critical commercial assays High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 4368813 SYBR green qPCR master mix Bioneer K-6251 mouse leptin ELISA Kit Crystal Chem 90030 ultrasensitive mouse Insulin ELISA kit Crystal Chem 90080 DNeasy Blood & Tissue kit Qiagen 69504 APO-BrdU Fragmentation Assay Kit BioVision K401 RNAqueous -Micro Kit Invitrogen AM1931 ECL Assay Kit PerkinElmer NEL104001EA Dual-Luciferase Reporter Assay System Promega E1980 Hydroxyproline Colorimetric Assay kit BioVision K555 Serum Triglyceride Determination Kit Sigma TR0100 Deposited data Whole genome bisulfite sequencing (WGBS) and RNA-sequencing of preadipocytes from iWAT N/A GSE214483 (Continued on next page) Cell Reports 42, 113196, October 31, 2023 15 .. REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines 3T3-L1 ATCC CL-173 HEK293T ATCC CRL-3216 Experimental models: Organisms/strains Mouse: C57BL/6J Jackson Laboratory 000664 Mouse: Pdgfra-Tet3 KO Dr. Anjana Rao and Jackson Laboratory N/A Oligonucleotides qPCR primer sequences Integrated DNA technologies Table S2 gRNA Integrated DNA technologies Table S2 ChIP-qPCR Integrated DNA technologies Table S2 MeDIP Integrated DNA technologies Table S2 Recombinant DNA pM2DG gift from Dr. Didier Trono Addgene, #12259 psPAX2 gift from Dr. Didier Trono Addgene, #12260 pCDH-CMV-MCS-EF1 System Biosciences CD510B-1 pLKO.1 gift from Dr. David Root74 Addgene, #10878 pLN-U6-gRNA Dr. Andreas Stahl N/A pCpGL3-Basic Dr. Michael Rehli N/A Software and algorithms QuantStudio 5 Applied Biosystems A34322 iBrightTM CL1500 Imaging System Invitrogen A44114 ImageJ National Institutes of Health https://imagej.nih.gov/ij/ Adiposoft75 Galarraga et al.75 https://drive.google.com/file/d/ 1TjfoogPQK2NB4VRpZxVn-BgcziCqrS8S/view Hisat276 Kim et al.76 https://github.com/DaehwanKimLab/hisat2 Htseq77 Anders et al.77 https://github.com/simon-anders/htseq Deseq278 Love et al.78 https://github.com/thelovelab/DESeq2 GSEApy79 Fang et al.79 https://github.com/zqfang/GSEApy/tree/v0.9.18 Bismark80 Krueger et al.80 https://github.com/FelixKrueger/Bismark DSS81 Wu et al.81 https://github.com/haowulab/DSS/ GREAT82 McLean et al.82 http://great.stanford.edu/public/html/ Homer83 Heinz, S. et al.83 http://homer.ucsd.edu/homer/ FastQC Andrews, S.84 https://github.com/s-andrews/FastQC TrimGalore Altos Labs https://github.com/FelixKrueger/TrimGalore GraphPad Prism GraphPad https://www.graphpad.com/ Other High fat diet Research Diets D12331i

    RNA sequencing:

    Article Title: TET3 plays a critical role in white adipose development and diet-induced remodeling.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies HSP-90 Cell Signaling Cat# 4874; RRID:AB_2121214 GAPDH Cell Signaling Cat# 2118; RRID:AB_561053 Mouse (G3A1) mAb IgG1 Cell Signaling Cat# 5415; RRID:AB_10829607 FLAG Sigma Cat# F3165; RRID:AB_259529 PDGFRa-PE Invitrogen Cat# 12-1401-81; AB_657615 CD45-APC BD Biosciences Cat# 561018; RRID:AB_10584326 CD31-APC BD Biosciences Cat# 561814; RRID:AB_10893351 TER119-APC BD Biosciences Cat# 561033; RRID:AB_10584336 5mc Abcam Cat# ab10805; RRID:AB_442823 5hmc Active Motif Cat# 39769; RRID:AB_10013602 PPARg Santa Cruz Cat# sc-7273; RRID:AB_628115 MAC-2 Cedarlane Labs Cat# CL8942AP; RRID:AB_10060357 TET3 Millipore Cat# abe383 Chemicals, peptides, and recombinant proteins Insulin Sigma I5500 Dexamethasone Sigma D2915 isobutylmethylxanthine Sigma I5879 Puromycin Sigma P8833 Oil Red O Sigma O0625-100G Methylene blue Ricca Chemical 4880–100 Collagenase type 2 Fisher scientific NC9693955 Recombinant CILP protein Abcam 182802 TRI Reagent Solution Invitrogen AM9738 Dynabeads Protein G Invitrogen 10004D Dynabeads anti-mouse IgG Fisher scientific 11-201-D Protein assay dye reagent Bio-Rad 5000006 BSA Sigma A7906 Lipofectamine 3000 Invitrogen L3000-015 Critical commercial assays High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 4368813 SYBR green qPCR master mix Bioneer K-6251 mouse leptin ELISA Kit Crystal Chem 90030 ultrasensitive mouse Insulin ELISA kit Crystal Chem 90080 DNeasy Blood & Tissue kit Qiagen 69504 APO-BrdU Fragmentation Assay Kit BioVision K401 RNAqueous -Micro Kit Invitrogen AM1931 ECL Assay Kit PerkinElmer NEL104001EA Dual-Luciferase Reporter Assay System Promega E1980 Hydroxyproline Colorimetric Assay kit BioVision K555 Serum Triglyceride Determination Kit Sigma TR0100 Deposited data Whole genome bisulfite sequencing (WGBS) and RNA-sequencing of preadipocytes from iWAT N/A GSE214483 (Continued on next page) Cell Reports 42, 113196, October 31, 2023 15 .. REAGENT or RESOURCE SOURCE IDENTIFIER Experimental models: Cell lines 3T3-L1 ATCC CL-173 HEK293T ATCC CRL-3216 Experimental models: Organisms/strains Mouse: C57BL/6J Jackson Laboratory 000664 Mouse: Pdgfra-Tet3 KO Dr. Anjana Rao and Jackson Laboratory N/A Oligonucleotides qPCR primer sequences Integrated DNA technologies Table S2 gRNA Integrated DNA technologies Table S2 ChIP-qPCR Integrated DNA technologies Table S2 MeDIP Integrated DNA technologies Table S2 Recombinant DNA pM2DG gift from Dr. Didier Trono Addgene, #12259 psPAX2 gift from Dr. Didier Trono Addgene, #12260 pCDH-CMV-MCS-EF1 System Biosciences CD510B-1 pLKO.1 gift from Dr. David Root74 Addgene, #10878 pLN-U6-gRNA Dr. Andreas Stahl N/A pCpGL3-Basic Dr. Michael Rehli N/A Software and algorithms QuantStudio 5 Applied Biosystems A34322 iBrightTM CL1500 Imaging System Invitrogen A44114 ImageJ National Institutes of Health https://imagej.nih.gov/ij/ Adiposoft75 Galarraga et al.75 https://drive.google.com/file/d/ 1TjfoogPQK2NB4VRpZxVn-BgcziCqrS8S/view Hisat276 Kim et al.76 https://github.com/DaehwanKimLab/hisat2 Htseq77 Anders et al.77 https://github.com/simon-anders/htseq Deseq278 Love et al.78 https://github.com/thelovelab/DESeq2 GSEApy79 Fang et al.79 https://github.com/zqfang/GSEApy/tree/v0.9.18 Bismark80 Krueger et al.80 https://github.com/FelixKrueger/Bismark DSS81 Wu et al.81 https://github.com/haowulab/DSS/ GREAT82 McLean et al.82 http://great.stanford.edu/public/html/ Homer83 Heinz, S. et al.83 http://homer.ucsd.edu/homer/ FastQC Andrews, S.84 https://github.com/s-andrews/FastQC TrimGalore Altos Labs https://github.com/FelixKrueger/TrimGalore GraphPad Prism GraphPad https://www.graphpad.com/ Other High fat diet Research Diets D12331i



    Similar Products

    96
    Cedarlane monoclonal antibody
    Monoclonal Antibody, supplied by Cedarlane, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl8942ap/Anti-Mouse%2FHuman+Mac-2+(Galectin-3)%2C+Purified+(Clone+M3%2F38)+(rat+IgG2a)/pmc13049657-436-25-27
    Average 96 stars, based on 1 article reviews
    monoclonal antibody - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cedarlane antigalectin 3
    Antigalectin 3, supplied by Cedarlane, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl8942ap/Anti-Mouse%2FHuman+Mac-2+(Galectin-3)%2C+Purified+(Clone+M3%2F38)+(rat+IgG2a)/pm41895269-370-46-48
    Average 96 stars, based on 1 article reviews
    antigalectin 3 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cedarlane blocking
    Blocking, supplied by Cedarlane, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl8942ap/Anti-Mouse%2FHuman+Mac-2+(Galectin-3)%2C+Purified+(Clone+M3%2F38)+(rat+IgG2a)/bio_rxiv__64898__2026__03__17__712297-81-6-13
    Average 96 stars, based on 1 article reviews
    blocking - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cedarlane cl8942ap
    Cl8942ap, supplied by Cedarlane, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl8942ap/Anti-Mouse%2FHuman+Mac-2+(Galectin-3)%2C+Purified+(Clone+M3%2F38)+(rat+IgG2a)/bio_rxiv__64898__2026__03__06__710174-253-16-14
    Average 96 stars, based on 1 article reviews
    cl8942ap - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cedarlane rat anti lgals3
    Rat Anti Lgals3, supplied by Cedarlane, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl8942ap/Anti-Mouse%2FHuman+Mac-2+(Galectin-3)%2C+Purified+(Clone+M3%2F38)+(rat+IgG2a)/bio_rxiv__64898__2026__03__06__710174-253-9-14
    Average 96 stars, based on 1 article reviews
    rat anti lgals3 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cedarlane mac2
    Mac2, supplied by Cedarlane, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl8942ap/Anti-Mouse%2FHuman+Mac-2+(Galectin-3)%2C+Purified+(Clone+M3%2F38)+(rat+IgG2a)/pm41794821-312-23-25
    Average 96 stars, based on 1 article reviews
    mac2 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    Cedarlane mac2 conjugated to alexa fluor 488
    Atherosclerosis regression is incomplete in Jak2 VF MPN mice with moderate cholesterol lowering. A: Study design created with BioRender.com. B: Plasma cholesterol (n = 34, 55, 55, 54, 16, 16 for Ctrl mice, n = 31, 55, 49, 39, 17, 16 for Jak2 VF mice, for weeks 0, 5, 11, 15, 17.5, 21 respectively). P = 0.028, <0.0001, <0.0001, <0.0001, 0.0005, <0.0001 (Ctrl vs. Jak2 VF at weeks 0, 5, 11, 15, 17.5, and 21, respectively). C: H&E images of aortic root lesions. Black lines , necrotic core. Scale bar, 200 μm. D: Lesion area, n = 15–23. P < 0.0001 (Ctrl Baseline vs. Jak2 VF Baseline; Ctrl LDL Lowering vs. Jak2 VF LDL Lowering), P = 0.052 ( Jak2 VF Baseline vs. LDL Lowering). E: Necrotic core area, n = 15–23. P = 0.0079 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.0002 (Ctrl LDL Lowering vs. Jak2 VF LDL Lowering), P = 0.0003 ( Jak2 VF Baseline vs. LDL Lowering). F: Picrosirius red-stained aortic root lesions. Scale bar, 200 μm. G: Collagen area as a percentage of lesion area, n = 15–24. P = 0.02 (Ctrl Baseline vs. LDL Lowering). H: Images of aortic root lesions stained for <t>MAC2</t> ( Green ) and DAPI ( Blue ). Scale bar, 200 μm. I: Macrophage area, n = 15–24. P = 0.006 (Ctrl Baseline vs. LDL Lowering), P = 0.16 ( Jak2 VF Baseline vs. LDL Lowering). All quantifications shown as mean ± s.e.m. Two-way ANOVA with the Geisser-Greenhouse correction for sphericity and Tukey’s multiple comparisons test (B). Two-way ANOVA with Tukey’s multiple comparisons test (D, E, G, and I). DAPI, 4′,6-diamidino-2-phenylindole; LDL, low-density lipoprotein; MPN, myeloproliferative neoplasm.
    Mac2 Conjugated To Alexa Fluor 488, supplied by Cedarlane, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl8942ap/Anti-Mouse%2FHuman+Mac-2+(Galectin-3)%2C+Purified+(Clone+M3%2F38)+(rat+IgG2a)/pmc13014939-217-53-59
    Average 96 stars, based on 1 article reviews
    mac2 conjugated to alexa fluor 488 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    Atherosclerosis regression is incomplete in Jak2 VF MPN mice with moderate cholesterol lowering. A: Study design created with BioRender.com. B: Plasma cholesterol (n = 34, 55, 55, 54, 16, 16 for Ctrl mice, n = 31, 55, 49, 39, 17, 16 for Jak2 VF mice, for weeks 0, 5, 11, 15, 17.5, 21 respectively). P = 0.028, <0.0001, <0.0001, <0.0001, 0.0005, <0.0001 (Ctrl vs. Jak2 VF at weeks 0, 5, 11, 15, 17.5, and 21, respectively). C: H&E images of aortic root lesions. Black lines , necrotic core. Scale bar, 200 μm. D: Lesion area, n = 15–23. P < 0.0001 (Ctrl Baseline vs. Jak2 VF Baseline; Ctrl LDL Lowering vs. Jak2 VF LDL Lowering), P = 0.052 ( Jak2 VF Baseline vs. LDL Lowering). E: Necrotic core area, n = 15–23. P = 0.0079 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.0002 (Ctrl LDL Lowering vs. Jak2 VF LDL Lowering), P = 0.0003 ( Jak2 VF Baseline vs. LDL Lowering). F: Picrosirius red-stained aortic root lesions. Scale bar, 200 μm. G: Collagen area as a percentage of lesion area, n = 15–24. P = 0.02 (Ctrl Baseline vs. LDL Lowering). H: Images of aortic root lesions stained for MAC2 ( Green ) and DAPI ( Blue ). Scale bar, 200 μm. I: Macrophage area, n = 15–24. P = 0.006 (Ctrl Baseline vs. LDL Lowering), P = 0.16 ( Jak2 VF Baseline vs. LDL Lowering). All quantifications shown as mean ± s.e.m. Two-way ANOVA with the Geisser-Greenhouse correction for sphericity and Tukey’s multiple comparisons test (B). Two-way ANOVA with Tukey’s multiple comparisons test (D, E, G, and I). DAPI, 4′,6-diamidino-2-phenylindole; LDL, low-density lipoprotein; MPN, myeloproliferative neoplasm.

    Journal: Journal of Lipid Research

    Article Title: Aggressive cholesterol lowering normalizes atherosclerosis regression in Jak2 V617F mice

    doi: 10.1016/j.jlr.2026.101003

    Figure Lengend Snippet: Atherosclerosis regression is incomplete in Jak2 VF MPN mice with moderate cholesterol lowering. A: Study design created with BioRender.com. B: Plasma cholesterol (n = 34, 55, 55, 54, 16, 16 for Ctrl mice, n = 31, 55, 49, 39, 17, 16 for Jak2 VF mice, for weeks 0, 5, 11, 15, 17.5, 21 respectively). P = 0.028, <0.0001, <0.0001, <0.0001, 0.0005, <0.0001 (Ctrl vs. Jak2 VF at weeks 0, 5, 11, 15, 17.5, and 21, respectively). C: H&E images of aortic root lesions. Black lines , necrotic core. Scale bar, 200 μm. D: Lesion area, n = 15–23. P < 0.0001 (Ctrl Baseline vs. Jak2 VF Baseline; Ctrl LDL Lowering vs. Jak2 VF LDL Lowering), P = 0.052 ( Jak2 VF Baseline vs. LDL Lowering). E: Necrotic core area, n = 15–23. P = 0.0079 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.0002 (Ctrl LDL Lowering vs. Jak2 VF LDL Lowering), P = 0.0003 ( Jak2 VF Baseline vs. LDL Lowering). F: Picrosirius red-stained aortic root lesions. Scale bar, 200 μm. G: Collagen area as a percentage of lesion area, n = 15–24. P = 0.02 (Ctrl Baseline vs. LDL Lowering). H: Images of aortic root lesions stained for MAC2 ( Green ) and DAPI ( Blue ). Scale bar, 200 μm. I: Macrophage area, n = 15–24. P = 0.006 (Ctrl Baseline vs. LDL Lowering), P = 0.16 ( Jak2 VF Baseline vs. LDL Lowering). All quantifications shown as mean ± s.e.m. Two-way ANOVA with the Geisser-Greenhouse correction for sphericity and Tukey’s multiple comparisons test (B). Two-way ANOVA with Tukey’s multiple comparisons test (D, E, G, and I). DAPI, 4′,6-diamidino-2-phenylindole; LDL, low-density lipoprotein; MPN, myeloproliferative neoplasm.

    Article Snippet: Following blocking, sections were incubated with the following primary antibodies at the indicated concentrations overnight at 4 °C in a humidified chamber: Absent in melanoma 2 (AIM2) (Abcam, ab119791, 1:250), Cleaved GasD (Cell Signaling, 10137, 10 μg/ml), c-Myc (Cell Signaling, 5605, 5.76 μg/ml), Ki67 (Abcam, ab15580, 9 μg/ml), MAC2 (Cedarlane, CL8942AP 1 μg/ml), MAC2 conjugated to Alexa Fluor 488 (Cedarlane, CL8942AF4, 1 μg/ml), mer proto-oncogene tyrosine kinase (MerTK) (R&D, BAF591, 2 μg/ml), pγH2AX (Cell Signaling, 9718, 0.74 μg/ml), ZsGreen (Thermo Fisher Scientific, TA180002, 10 μg/ml), triggering receptor expressed on myeloid cells 2 (TREM2) (Denali, 4D9 DC1847, 1:100).

    Techniques: Clinical Proteomics, Staining

    Aggressive cholesterol lowering normalizes regression in Jak2 VF MPN lesions. A: Study design, created with BioRender.com. B: Plasma cholesterol (n = 5, 38, 19, 18, and 18 for Ctrl mice, n = 5, 37, 15, 16, and 15 for Jak2 VF mice, for weeks 0, 4, 13, 15, and 18, respectively). P = 0.0041 for genotype effect by two-way ANOVA with Geisser-Greenhouse correction, P = 0.011, 0.048, 0.056, and 0.0008 (Ctrl vs. Jak2 VF at weeks 0, 4, 13, and 15, respectively). C: H&E images of aortic root lesions. Black lines , necrotic core. Scale bar, 200 μm. D: Lesion area, n = 13–20. P < 0.0001 (Ctrl Baseline vs. Jak2 VF Baseline; Ctrl LDL Lowering vs. Jak2 VF LDL Lowering). Figures 1 and 4 represent independent regression cohorts performed separately; therefore, absolute lesion area should be compared within each cohort rather than between figures. E: Necrotic core area, n = 13–20. P = 0.0003 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.0006 (Ctrl LDL Lowering vs. Jak2 VF LDL Lowering), P = 0.90 ( Jak2 VF Baseline vs. LDL Lowering). F: Picrosirius red-stained aortic root lesions. Scale bar, 200 μm. G: Collagen area as a percentage of lesion area, n = 13–20. P < 0.0001 (Ctrl Baseline vs. LDL Lowering), P = 0.0002 ( Jak2 VF Baseline vs. LDL Lowering), P = 0.02 (Ctrl LDL Lowering vs. Jak2 VF LDL Lowering). H: Images of aortic root lesions stained for MAC2 ( Green ) and DAPI ( Blue ). Scale bar, 200 μm. I: Macrophage area, n = 13–20. P < 0.0001 (Ctrl and Jak2 VF Baseline vs. LDL Lowering). All quantifications shown as mean ± s.e.m. Two-way ANOVA with Tukey’s multiple comparisons test (D, G, and I). Two-way ANOVA with the Geisser-Greenhouse correction for sphericity and Tukey’s multiple comparisons test (B). Kruskal-Wallis test with Dunn’s multiple comparisons test (E). DAPI, 4′,6-diamidino-2-phenylindole; LDL, low-density lipoprotein; MPN, myeloproliferative neoplasm.

    Journal: Journal of Lipid Research

    Article Title: Aggressive cholesterol lowering normalizes atherosclerosis regression in Jak2 V617F mice

    doi: 10.1016/j.jlr.2026.101003

    Figure Lengend Snippet: Aggressive cholesterol lowering normalizes regression in Jak2 VF MPN lesions. A: Study design, created with BioRender.com. B: Plasma cholesterol (n = 5, 38, 19, 18, and 18 for Ctrl mice, n = 5, 37, 15, 16, and 15 for Jak2 VF mice, for weeks 0, 4, 13, 15, and 18, respectively). P = 0.0041 for genotype effect by two-way ANOVA with Geisser-Greenhouse correction, P = 0.011, 0.048, 0.056, and 0.0008 (Ctrl vs. Jak2 VF at weeks 0, 4, 13, and 15, respectively). C: H&E images of aortic root lesions. Black lines , necrotic core. Scale bar, 200 μm. D: Lesion area, n = 13–20. P < 0.0001 (Ctrl Baseline vs. Jak2 VF Baseline; Ctrl LDL Lowering vs. Jak2 VF LDL Lowering). Figures 1 and 4 represent independent regression cohorts performed separately; therefore, absolute lesion area should be compared within each cohort rather than between figures. E: Necrotic core area, n = 13–20. P = 0.0003 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.0006 (Ctrl LDL Lowering vs. Jak2 VF LDL Lowering), P = 0.90 ( Jak2 VF Baseline vs. LDL Lowering). F: Picrosirius red-stained aortic root lesions. Scale bar, 200 μm. G: Collagen area as a percentage of lesion area, n = 13–20. P < 0.0001 (Ctrl Baseline vs. LDL Lowering), P = 0.0002 ( Jak2 VF Baseline vs. LDL Lowering), P = 0.02 (Ctrl LDL Lowering vs. Jak2 VF LDL Lowering). H: Images of aortic root lesions stained for MAC2 ( Green ) and DAPI ( Blue ). Scale bar, 200 μm. I: Macrophage area, n = 13–20. P < 0.0001 (Ctrl and Jak2 VF Baseline vs. LDL Lowering). All quantifications shown as mean ± s.e.m. Two-way ANOVA with Tukey’s multiple comparisons test (D, G, and I). Two-way ANOVA with the Geisser-Greenhouse correction for sphericity and Tukey’s multiple comparisons test (B). Kruskal-Wallis test with Dunn’s multiple comparisons test (E). DAPI, 4′,6-diamidino-2-phenylindole; LDL, low-density lipoprotein; MPN, myeloproliferative neoplasm.

    Article Snippet: Following blocking, sections were incubated with the following primary antibodies at the indicated concentrations overnight at 4 °C in a humidified chamber: Absent in melanoma 2 (AIM2) (Abcam, ab119791, 1:250), Cleaved GasD (Cell Signaling, 10137, 10 μg/ml), c-Myc (Cell Signaling, 5605, 5.76 μg/ml), Ki67 (Abcam, ab15580, 9 μg/ml), MAC2 (Cedarlane, CL8942AP 1 μg/ml), MAC2 conjugated to Alexa Fluor 488 (Cedarlane, CL8942AF4, 1 μg/ml), mer proto-oncogene tyrosine kinase (MerTK) (R&D, BAF591, 2 μg/ml), pγH2AX (Cell Signaling, 9718, 0.74 μg/ml), ZsGreen (Thermo Fisher Scientific, TA180002, 10 μg/ml), triggering receptor expressed on myeloid cells 2 (TREM2) (Denali, 4D9 DC1847, 1:100).

    Techniques: Clinical Proteomics, Staining

    Cholesterol lowering suppresses Jak2 VF macrophage proliferation and DNA damage. A: Study design created with BioRender.com. B: Plasma cholesterol (n = 79, 78, and 78 for Baseline mice for weeks 3, 11, and 15, respectively; n = 13, 14 for Ctrl Progression mice, n = 16, 16 for Ctrl LDL Lowering mice, n = 15, 15 for Jak2 VF Progression mice, n = 16, 16 for Jak2 VF LDL Lowering mice, for weeks 18 and 23, respectively). C: Images of aortic root lesions for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. D: Log 10 transformed cleaved GasD mean fluorescence intensity (MFI) in lesions with the addition of constant 1, n = 14–16. P = 0.01 (Baseline vs. Jak2 VF Progression), P = 0.051 ( Jak2 VF Progression vs. Jak2 VF LDL Lowering). E: Log 10 transformed cleaved GasD MFI in the necrotic core with the addition of constant 1, n = 14–16. P = 0.04 (Baseline vs. Jak2 VF Progression), P = 0.013 ( Jak2 VF Progression vs. Jak2 VF LDL Lowering). F: Images of aortic root lesions stained for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , cleaved GasD + macrophages. G: Log 10 transformed cleaved GasD positive macrophages per section with the addition of constant 1, n = 14–16. H: Images of aortic root lesions for MAC2 ( Red ), Ki67 ( White ), and ZsGreen ( Green ). Scale bar, 60 μm. White arrows , macrophages double positive for Ki67 and ZsGreen. I: Macrophages positive for both Ki67 and ZsGreen per section, n = 13–15. P = 0.0019 (Baseline vs. Jak2 VF Progression), P = 0.0006 (Ctrl Progression vs. Jak2 VF Progression), P = 0.0003 ( Jak2 VF Progression vs. Jak2 VF LDL Lowering). J: Macrophages positive for Ki67 but negative for ZsGreen per section, n = 13–16. K: Images of aortic root lesions stained for pγH2AX ( Red ), ZsGreen ( Green ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows, pγH2AX positive cells. L: Log 10 transformed cells double positive for pγH2AX and ZsGreen in lesions with the addition of constant 1, n = 13–16. P = 0.0024 (Baseline vs. Jak2 VF Progression), P = 0.0019 ( Jak2 VF Progression vs. Jak2 VF LDL Lowering). M: Log 10 transformed cells positive for pγH2AX but negative for ZsGreen in lesions with the addition of constant 1, n = 13–16. All quantifications shown as mean ± s.e.m. One-way ANOVA with Holm–Sidak’s multiple comparisons test (D and E). Kruskal–Wallis test with Dunn’s multiple comparison’s test (G, I, J, L, and M). DAPI, 4′,6-diamidino-2-phenylindole; GasD, gasdermin D; LDL, low-density lipoprotein; pγH2AX, phosphorylated histone H2A.X.

    Journal: Journal of Lipid Research

    Article Title: Aggressive cholesterol lowering normalizes atherosclerosis regression in Jak2 V617F mice

    doi: 10.1016/j.jlr.2026.101003

    Figure Lengend Snippet: Cholesterol lowering suppresses Jak2 VF macrophage proliferation and DNA damage. A: Study design created with BioRender.com. B: Plasma cholesterol (n = 79, 78, and 78 for Baseline mice for weeks 3, 11, and 15, respectively; n = 13, 14 for Ctrl Progression mice, n = 16, 16 for Ctrl LDL Lowering mice, n = 15, 15 for Jak2 VF Progression mice, n = 16, 16 for Jak2 VF LDL Lowering mice, for weeks 18 and 23, respectively). C: Images of aortic root lesions for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. D: Log 10 transformed cleaved GasD mean fluorescence intensity (MFI) in lesions with the addition of constant 1, n = 14–16. P = 0.01 (Baseline vs. Jak2 VF Progression), P = 0.051 ( Jak2 VF Progression vs. Jak2 VF LDL Lowering). E: Log 10 transformed cleaved GasD MFI in the necrotic core with the addition of constant 1, n = 14–16. P = 0.04 (Baseline vs. Jak2 VF Progression), P = 0.013 ( Jak2 VF Progression vs. Jak2 VF LDL Lowering). F: Images of aortic root lesions stained for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , cleaved GasD + macrophages. G: Log 10 transformed cleaved GasD positive macrophages per section with the addition of constant 1, n = 14–16. H: Images of aortic root lesions for MAC2 ( Red ), Ki67 ( White ), and ZsGreen ( Green ). Scale bar, 60 μm. White arrows , macrophages double positive for Ki67 and ZsGreen. I: Macrophages positive for both Ki67 and ZsGreen per section, n = 13–15. P = 0.0019 (Baseline vs. Jak2 VF Progression), P = 0.0006 (Ctrl Progression vs. Jak2 VF Progression), P = 0.0003 ( Jak2 VF Progression vs. Jak2 VF LDL Lowering). J: Macrophages positive for Ki67 but negative for ZsGreen per section, n = 13–16. K: Images of aortic root lesions stained for pγH2AX ( Red ), ZsGreen ( Green ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows, pγH2AX positive cells. L: Log 10 transformed cells double positive for pγH2AX and ZsGreen in lesions with the addition of constant 1, n = 13–16. P = 0.0024 (Baseline vs. Jak2 VF Progression), P = 0.0019 ( Jak2 VF Progression vs. Jak2 VF LDL Lowering). M: Log 10 transformed cells positive for pγH2AX but negative for ZsGreen in lesions with the addition of constant 1, n = 13–16. All quantifications shown as mean ± s.e.m. One-way ANOVA with Holm–Sidak’s multiple comparisons test (D and E). Kruskal–Wallis test with Dunn’s multiple comparison’s test (G, I, J, L, and M). DAPI, 4′,6-diamidino-2-phenylindole; GasD, gasdermin D; LDL, low-density lipoprotein; pγH2AX, phosphorylated histone H2A.X.

    Article Snippet: Following blocking, sections were incubated with the following primary antibodies at the indicated concentrations overnight at 4 °C in a humidified chamber: Absent in melanoma 2 (AIM2) (Abcam, ab119791, 1:250), Cleaved GasD (Cell Signaling, 10137, 10 μg/ml), c-Myc (Cell Signaling, 5605, 5.76 μg/ml), Ki67 (Abcam, ab15580, 9 μg/ml), MAC2 (Cedarlane, CL8942AP 1 μg/ml), MAC2 conjugated to Alexa Fluor 488 (Cedarlane, CL8942AF4, 1 μg/ml), mer proto-oncogene tyrosine kinase (MerTK) (R&D, BAF591, 2 μg/ml), pγH2AX (Cell Signaling, 9718, 0.74 μg/ml), ZsGreen (Thermo Fisher Scientific, TA180002, 10 μg/ml), triggering receptor expressed on myeloid cells 2 (TREM2) (Denali, 4D9 DC1847, 1:100).

    Techniques: Clinical Proteomics, Transformation Assay, Fluorescence, Staining

    Moderate cholesterol lowering reverses macrophage AIM2 inflammasome activation, DNA damage, and proliferation in Jak2 VF MPN lesions. A: Images of aortic root lesions stained for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. B: Log 10 transformed cleaved GasD mean fluorescence intensity (MFI) in lesions with the addition of constant 1, n = 15–24. P = 0.021 (Ctrl Baseline vs. Jak2 VF Baseline). C: Log 10 transformed cleaved GasD mean fluorescence intensity (MFI) in necrotic cores with the addition of constant 1, n = 15–24. P = 0.0008 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.032 (Ctrl LDL Lowering vs. Jak2 VF LDL Lowering). D: Images of aortic root lesions stained for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , cleaved GasD + macrophages. E: Log 10 transformed cleaved GasD positive macrophages per section with the addition of constant 1, n = 15–24. P = 0.024 ( Jak2 VF Baseline vs. LDL Lowering). F: Images of aortic root lesions stained for MAC2 ( Green ), AIM2 ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , AIM2 positive macrophages. G: Log 10 transformed AIM2 positive macrophages per section with the addition of constant 1, n = 15–23. P = 0.0001 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.03 ( Jak2 VF Baseline vs. LDL Lowering). H: Images of aortic root lesions stained for MAC2 ( Green ), pγH2AX ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , pγH2AX positive cells. I: Log 10 transformed pγH2AX positive cells per section with the addition of constant 1, n = 15–23. P = 0.0019 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.045 ( Jak2 VF Baseline vs. LDL Lowering). J: Images of aortic root lesions stained for MAC2 ( Green ), Ki67 ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , Ki67 positive macrophages. K: Log 10 transformed Ki67 positive macrophages per section with the addition of constant 1, n = 15–23. P = 0.0019 ( Jak2 VF Baseline vs. LDL Lowering). MAC2 intensity differences reflect independent staining and imaging sessions across panels. All quantifications shown as mean ± s.e.m. Two-way ANOVA with Tukey’s multiple comparisons test (B and C). Kruskal–Wallis test with Dunn’s multiple comparisons test (E, G, I, and K). AIM2, absent in melanoma 2; DAPI, 4′,6-diamidino-2-phenylindole; GasD, gasdermin D; LDL, low-density lipoprotein; MPN, myeloproliferative neoplasm; pγH2AX, phosphorylated histone H2A.X.

    Journal: Journal of Lipid Research

    Article Title: Aggressive cholesterol lowering normalizes atherosclerosis regression in Jak2 V617F mice

    doi: 10.1016/j.jlr.2026.101003

    Figure Lengend Snippet: Moderate cholesterol lowering reverses macrophage AIM2 inflammasome activation, DNA damage, and proliferation in Jak2 VF MPN lesions. A: Images of aortic root lesions stained for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. B: Log 10 transformed cleaved GasD mean fluorescence intensity (MFI) in lesions with the addition of constant 1, n = 15–24. P = 0.021 (Ctrl Baseline vs. Jak2 VF Baseline). C: Log 10 transformed cleaved GasD mean fluorescence intensity (MFI) in necrotic cores with the addition of constant 1, n = 15–24. P = 0.0008 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.032 (Ctrl LDL Lowering vs. Jak2 VF LDL Lowering). D: Images of aortic root lesions stained for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , cleaved GasD + macrophages. E: Log 10 transformed cleaved GasD positive macrophages per section with the addition of constant 1, n = 15–24. P = 0.024 ( Jak2 VF Baseline vs. LDL Lowering). F: Images of aortic root lesions stained for MAC2 ( Green ), AIM2 ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , AIM2 positive macrophages. G: Log 10 transformed AIM2 positive macrophages per section with the addition of constant 1, n = 15–23. P = 0.0001 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.03 ( Jak2 VF Baseline vs. LDL Lowering). H: Images of aortic root lesions stained for MAC2 ( Green ), pγH2AX ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , pγH2AX positive cells. I: Log 10 transformed pγH2AX positive cells per section with the addition of constant 1, n = 15–23. P = 0.0019 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.045 ( Jak2 VF Baseline vs. LDL Lowering). J: Images of aortic root lesions stained for MAC2 ( Green ), Ki67 ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , Ki67 positive macrophages. K: Log 10 transformed Ki67 positive macrophages per section with the addition of constant 1, n = 15–23. P = 0.0019 ( Jak2 VF Baseline vs. LDL Lowering). MAC2 intensity differences reflect independent staining and imaging sessions across panels. All quantifications shown as mean ± s.e.m. Two-way ANOVA with Tukey’s multiple comparisons test (B and C). Kruskal–Wallis test with Dunn’s multiple comparisons test (E, G, I, and K). AIM2, absent in melanoma 2; DAPI, 4′,6-diamidino-2-phenylindole; GasD, gasdermin D; LDL, low-density lipoprotein; MPN, myeloproliferative neoplasm; pγH2AX, phosphorylated histone H2A.X.

    Article Snippet: Following blocking, sections were incubated with the following primary antibodies at the indicated concentrations overnight at 4 °C in a humidified chamber: Absent in melanoma 2 (AIM2) (Abcam, ab119791, 1:250), Cleaved GasD (Cell Signaling, 10137, 10 μg/ml), c-Myc (Cell Signaling, 5605, 5.76 μg/ml), Ki67 (Abcam, ab15580, 9 μg/ml), MAC2 (Cedarlane, CL8942AP 1 μg/ml), MAC2 conjugated to Alexa Fluor 488 (Cedarlane, CL8942AF4, 1 μg/ml), mer proto-oncogene tyrosine kinase (MerTK) (R&D, BAF591, 2 μg/ml), pγH2AX (Cell Signaling, 9718, 0.74 μg/ml), ZsGreen (Thermo Fisher Scientific, TA180002, 10 μg/ml), triggering receptor expressed on myeloid cells 2 (TREM2) (Denali, 4D9 DC1847, 1:100).

    Techniques: Activation Assay, Staining, Transformation Assay, Fluorescence, Imaging

    Moderate cholesterol lowering reverses impaired efferocytosis in Jak2 VF MPN lesions while increasing TREM2 Hi macrophages in control and Jak2 VF MPN lesions. A: Images of aortic root lesions stained for MAC2 ( Green ), MerTK ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. B: Percentage of MAC2 positive area double positive for MerTK and MAC2, n = 15–23. P = 0.02 (Ctrl Baseline vs. Jak2 VF Baseline), P < 0.0001 ( Jak2 VF Baseline vs. LDL Lowering). C: Images of aortic root lesions stained for MAC2 ( Green ), TREM2 ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. D: Percentage of MAC2 positive area double positive for TREM2 and MAC2, n = 15–24. P < 0.0001 (Ctrl and Jak2 VF Baseline vs. LDL Lowering). E: Images of in situ efferocytosis in aortic root lesions: MAC2 ( Green ), TUNEL ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , nuclei double positive for TUNEL and MAC2. White wedges , nuclei positive for TUNEL but negative for MAC2. F: Percentage of TUNEL positive nuclei also positive for MAC2. P = 0.011 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.021 ( Jak2 VF Baseline vs. LDL Lowering). MAC2 intensity differences reflect independent staining and imaging sessions across panels, n = 13–24. All quantifications shown as mean ± s.e.m. Two-way ANOVA with Tukey’s multiple comparisons test (D). Kruskal-Wallis test with Dunn’s multiple comparisons test (B and F). DAPI, 4′,6-diamidino-2-phenylindole; LDL, low-density lipoprotein; MerTK, mer proto-oncogene tyrosine kinase; MPN, myeloproliferative neoplasm; TREM2, triggering receptor expressed on myeloid cells 2.

    Journal: Journal of Lipid Research

    Article Title: Aggressive cholesterol lowering normalizes atherosclerosis regression in Jak2 V617F mice

    doi: 10.1016/j.jlr.2026.101003

    Figure Lengend Snippet: Moderate cholesterol lowering reverses impaired efferocytosis in Jak2 VF MPN lesions while increasing TREM2 Hi macrophages in control and Jak2 VF MPN lesions. A: Images of aortic root lesions stained for MAC2 ( Green ), MerTK ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. B: Percentage of MAC2 positive area double positive for MerTK and MAC2, n = 15–23. P = 0.02 (Ctrl Baseline vs. Jak2 VF Baseline), P < 0.0001 ( Jak2 VF Baseline vs. LDL Lowering). C: Images of aortic root lesions stained for MAC2 ( Green ), TREM2 ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. D: Percentage of MAC2 positive area double positive for TREM2 and MAC2, n = 15–24. P < 0.0001 (Ctrl and Jak2 VF Baseline vs. LDL Lowering). E: Images of in situ efferocytosis in aortic root lesions: MAC2 ( Green ), TUNEL ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , nuclei double positive for TUNEL and MAC2. White wedges , nuclei positive for TUNEL but negative for MAC2. F: Percentage of TUNEL positive nuclei also positive for MAC2. P = 0.011 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.021 ( Jak2 VF Baseline vs. LDL Lowering). MAC2 intensity differences reflect independent staining and imaging sessions across panels, n = 13–24. All quantifications shown as mean ± s.e.m. Two-way ANOVA with Tukey’s multiple comparisons test (D). Kruskal-Wallis test with Dunn’s multiple comparisons test (B and F). DAPI, 4′,6-diamidino-2-phenylindole; LDL, low-density lipoprotein; MerTK, mer proto-oncogene tyrosine kinase; MPN, myeloproliferative neoplasm; TREM2, triggering receptor expressed on myeloid cells 2.

    Article Snippet: Following blocking, sections were incubated with the following primary antibodies at the indicated concentrations overnight at 4 °C in a humidified chamber: Absent in melanoma 2 (AIM2) (Abcam, ab119791, 1:250), Cleaved GasD (Cell Signaling, 10137, 10 μg/ml), c-Myc (Cell Signaling, 5605, 5.76 μg/ml), Ki67 (Abcam, ab15580, 9 μg/ml), MAC2 (Cedarlane, CL8942AP 1 μg/ml), MAC2 conjugated to Alexa Fluor 488 (Cedarlane, CL8942AF4, 1 μg/ml), mer proto-oncogene tyrosine kinase (MerTK) (R&D, BAF591, 2 μg/ml), pγH2AX (Cell Signaling, 9718, 0.74 μg/ml), ZsGreen (Thermo Fisher Scientific, TA180002, 10 μg/ml), triggering receptor expressed on myeloid cells 2 (TREM2) (Denali, 4D9 DC1847, 1:100).

    Techniques: Control, Staining, In Situ, TUNEL Assay, Imaging

    Aggressive cholesterol lowering more strongly decreases macrophage pyroptosis and DNA damage in Jak2 VF MPN lesions. A: Images of aortic root lesions stained for MAC2 ( Green ), cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. B: Log 10 transformed cleaved GasD MFI in the necrotic core with the addition of constant 1, n = 14–20. P = 0.0064 for genotype effect and P = 0.021 for treatment effect by two-way ANOVA. C: Images of aortic root lesions stained for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , cleaved GasD + macrophages. D: Log 10 transformed cleaved GasD positive macrophages per section with the addition of constant 1, n = 13–20. P = 0.023 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.005 ( Jak2 VF Baseline vs. LDL Lowering). E: Representative immunoblot analysis of full-length and cleaved GasD in CD11b + splenocytes. F: Log 10 transformed densitometric quantification of the ratio of cleaved GasD to full-length GasD from E with the addition of constant 1. n = 7–8 biological replicates. P = 0.0003 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.0046 ( Jak2 VF Baseline vs. LDL Lowering). G: Images of aortic root lesions stained for MAC2 ( Green ), pγH2AX ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , pγH2AX positive cells. H: Log 10 transformed pγH2AX positive cells per section with the addition of constant 1, n = 14–20. P = 0.016 (Ctrl Baseline vs. LDL Lowering), P = 0.0016 (Ctrl Baseline vs. Jak2 VF Baseline), P < 0.0001 ( Jak2 VF Baseline vs. LDL Lowering). All quantifications shown as mean ± s.e.m. Two-way ANOVA with Tukey’s multiple comparisons test (B, D, F, and H). DAPI, 4′,6-diamidino-2-phenylindole; GasD, gasdermin D; LDL, low-density lipoprotein; MFI, mean fluorescence intensity; MPN, myeloproliferative neoplasm; pγH2AX, phosphorylated histone H2A.X.

    Journal: Journal of Lipid Research

    Article Title: Aggressive cholesterol lowering normalizes atherosclerosis regression in Jak2 V617F mice

    doi: 10.1016/j.jlr.2026.101003

    Figure Lengend Snippet: Aggressive cholesterol lowering more strongly decreases macrophage pyroptosis and DNA damage in Jak2 VF MPN lesions. A: Images of aortic root lesions stained for MAC2 ( Green ), cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. B: Log 10 transformed cleaved GasD MFI in the necrotic core with the addition of constant 1, n = 14–20. P = 0.0064 for genotype effect and P = 0.021 for treatment effect by two-way ANOVA. C: Images of aortic root lesions stained for MAC2 ( Green ), Cleaved GasD ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , cleaved GasD + macrophages. D: Log 10 transformed cleaved GasD positive macrophages per section with the addition of constant 1, n = 13–20. P = 0.023 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.005 ( Jak2 VF Baseline vs. LDL Lowering). E: Representative immunoblot analysis of full-length and cleaved GasD in CD11b + splenocytes. F: Log 10 transformed densitometric quantification of the ratio of cleaved GasD to full-length GasD from E with the addition of constant 1. n = 7–8 biological replicates. P = 0.0003 (Ctrl Baseline vs. Jak2 VF Baseline), P = 0.0046 ( Jak2 VF Baseline vs. LDL Lowering). G: Images of aortic root lesions stained for MAC2 ( Green ), pγH2AX ( Red ), and DAPI ( Blue ). Scale bar, 60 μm. White arrows , pγH2AX positive cells. H: Log 10 transformed pγH2AX positive cells per section with the addition of constant 1, n = 14–20. P = 0.016 (Ctrl Baseline vs. LDL Lowering), P = 0.0016 (Ctrl Baseline vs. Jak2 VF Baseline), P < 0.0001 ( Jak2 VF Baseline vs. LDL Lowering). All quantifications shown as mean ± s.e.m. Two-way ANOVA with Tukey’s multiple comparisons test (B, D, F, and H). DAPI, 4′,6-diamidino-2-phenylindole; GasD, gasdermin D; LDL, low-density lipoprotein; MFI, mean fluorescence intensity; MPN, myeloproliferative neoplasm; pγH2AX, phosphorylated histone H2A.X.

    Article Snippet: Following blocking, sections were incubated with the following primary antibodies at the indicated concentrations overnight at 4 °C in a humidified chamber: Absent in melanoma 2 (AIM2) (Abcam, ab119791, 1:250), Cleaved GasD (Cell Signaling, 10137, 10 μg/ml), c-Myc (Cell Signaling, 5605, 5.76 μg/ml), Ki67 (Abcam, ab15580, 9 μg/ml), MAC2 (Cedarlane, CL8942AP 1 μg/ml), MAC2 conjugated to Alexa Fluor 488 (Cedarlane, CL8942AF4, 1 μg/ml), mer proto-oncogene tyrosine kinase (MerTK) (R&D, BAF591, 2 μg/ml), pγH2AX (Cell Signaling, 9718, 0.74 μg/ml), ZsGreen (Thermo Fisher Scientific, TA180002, 10 μg/ml), triggering receptor expressed on myeloid cells 2 (TREM2) (Denali, 4D9 DC1847, 1:100).

    Techniques: Staining, Transformation Assay, Western Blot, Fluorescence